Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017 (2017), Article ID 1764549, 12 pages
https://doi.org/10.1155/2017/1764549
Research Article

Mitochondrial DNA Hypomethylation Is a Biomarker Associated with Induced Senescence in Human Fetal Heart Mesenchymal Stem Cells

1Stem Cell and Cancer Center, The First Bethune Hospital, Jilin University, Changchun, Jilin 130061, China
2Stanford University Medical School, Palo Alto Veterans Institute for Research, Palo Alto, CA 94304, USA
3Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, USA

Correspondence should be addressed to Pinchas Cohen, Jiuwei Cui, Andrew R. Hoffman, and Ji-Fan Hu

Received 18 October 2016; Revised 5 January 2017; Accepted 16 January 2017; Published 6 April 2017

Academic Editor: Martin Stimpfel

Copyright © 2017 Dehai Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. R. Porrello and E. N. Olson, “A neonatal blueprint for cardiac regeneration,” Stem Cell Research, vol. 13, no. 3, pp. 556–570, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. E. R. Porrello, A. I. Mahmoud, E. Simpson et al., “Transient regenerative potential of the neonatal mouse heart,” Science, vol. 331, no. 6020, pp. 1078–1080, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. J. H. Chong, V. Chandrakanthan, M. Xaymardan et al., “Adult cardiac-resident MSC-like stem cells with a proepicardial origin,” Cell Stem Cell, vol. 9, no. 6, pp. 527–540, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Tirosh-Finkel, A. Zeisel, M. Brodt-Ivenshitz et al., “BMP-mediated inhibition of FGF signaling promotes cardiomyocyte differentiation of anterior heart field progenitors,” Development, vol. 137, no. 18, pp. 2989–3000, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Kloesel, J. A. Dinardo, and S. C. Body, “Cardiac embryology and molecular mechanisms of congenital heart disease: a primer for anesthesiologists,” Anesthesia and Analgesia, vol. 123, no. 3, pp. 551–569, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. M. J. Birket and C. L. Mummery, “Pluripotent stem cell derived cardiovascular progenitors—a developmental perspective,” Developmental Biology, vol. 400, no. 2, pp. 169–179, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Greulich, C. Rudat, and A. Kispert, “Mechanisms of T-box gene function in the developing heart,” Cardiovascular Research, vol. 91, no. 2, pp. 212–222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. van Weerd and V. M. Christoffels, “The formation and function of the cardiac conduction system,” Development, vol. 143, no. 2, pp. 197–210, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Wang, X. Chen, W. Cao, and Y. Shi, “Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications,” Nature Immunology, vol. 15, no. 11, pp. 1009–1016, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. M. T. Sutton and T. L. Bonfield, “Stem cells: innovations in clinical applications,” Stem Cells International, vol. 2014, Article ID 516278, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Amorin, A. P. Alegretti, V. Valim et al., “Mesenchymal stem cell therapy and acute graft-versus-host disease: a review,” Human Cell, vol. 27, no. 4, pp. 137–150, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Barry and M. Murphy, “Mesenchymal stem cells in joint disease and repair,” Nature Reviews Rheumatology, vol. 9, no. 10, pp. 584–594, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Mundra, I. C. Gerling, and R. I. Mahato, “Mesenchymal stem cell-based therapy,” Molecular Pharmaceutics, vol. 10, no. 1, pp. 77–89, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. R. A. Pelekanos, J. Li, M. Gongora et al., “Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities,” Stem Cell Research, vol. 8, no. 1, pp. 58–73, 2012. View at Publisher · View at Google Scholar
  15. D. N. Silva, B. S. De Freitas Souza, C. M. Azevedo et al., “Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy,” Stem Cell Research and Therapy, vol. 5, no. 4, article no. 81, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. G. V. N. Srikanth, N. K. Tripathy, and S. Nityanand, “Fetal cardiac mesenchymal stem cells express embryonal markers and exhibit differentiation into cells of all three germ layers,” World Journal of Stem Cells, vol. 5, no. 1, pp. 26–33, 2013. View at Publisher · View at Google Scholar
  17. A. I. Hoch and J. Kent Leach, “Concise review: Optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications,” Stem Cells Translational Medicine, vol. 3, no. 5, pp. 643–652, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Bajek, M. Czerwinski, J. Olkowska, N. Gurtowska, T. Kloskowski, and T. Drewa, “Does aging of mesenchymal stem cells limit their potential application in clinical practice?” Aging Clinical and Experimental Research, vol. 24, no. 5, pp. 404–411, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Książek, “A comprehensive review on mesenchymal stem cell growth and senescence,” Rejuvenation Research, vol. 12, no. 2, pp. 105–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. D. Kretlow, Y.-Q. Jin, W. Liu et al., “Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells,” BMC Cell Biology, vol. 9, article 60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. P. Valyushina and L. B. Buravkova, “Age-related differences in rat multipotent mesenchymal stromal bone marrow cells,” Bulletin of Experimental Biology and Medicine, vol. 155, no. 1, pp. 129–133, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Zaim, S. Karaman, G. Cetin, and S. Isik, “Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells,” Annals of Hematology, vol. 91, no. 8, pp. 1175–1186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. Z.-Y. Zhang, S.-H. Teoh, M. S. K. Chong et al., “Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells,” Stem Cells, vol. 27, no. 1, pp. 126–137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Stolzing, E. Jones, D. McGonagle, and A. Scutt, “Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies,” Mechanisms of Ageing and Development, vol. 129, no. 3, pp. 163–173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. A. Babizhayev and Y. E. Yegorov, “Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies,” Journal of Biomedical Materials Research Part A, vol. 103, no. 12, pp. 3993–4023, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. T. A. Weber and A. S. Reichert, “Impaired quality control of mitochondria: aging from a new perspective,” Experimental Gerontology, vol. 45, no. 7-8, pp. 503–511, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. D. V. Ziegler, C. D. Wiley, and M. C. Velarde, “Mitochondrial effectors of cellular senescence: beyond the free radical theory of aging,” Aging Cell, vol. 14, no. 1, pp. 1–7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. E. E. Hong, A. D. Smith, C. Y. Okitsu, and C.-L. Hsieh, “Regionally specific and genome-wide analyses conclusively demonstrate the absence of CpG methylation in human mitochondrial DNA,” Molecular and Cellular Biology, vol. 33, no. 14, pp. 2683–2690, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Dzitoyeva, H. Chen, and H. Manev, “Effect of aging on 5-hydroxymethylcytosine in brain mitochondria,” Neurobiology of Aging, vol. 33, no. 12, pp. 2881–2891, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Iacobazzi, A. Castegna, V. Infantino, and G. Andria, “Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool,” Molecular Genetics and Metabolism, vol. 110, no. 1-2, pp. 25–34, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Jin, Y. Chen, Y. Zhou et al., “Transplantation of bone marrow-derived mesenchymal stem cells expressing elastin alleviates pelvic floor dysfunction,” Stem Cell Research & Therapy, vol. 7, no. 1, article 51, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Chen, A. Yue, Z. Ruan et al., “Comparison of biological characteristics of mesenchymal stem cells derived from maternal-origin placenta and Wharton's jelly,” Stem Cell Research and Therapy, vol. 6, no. 1, article no. 228, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Liu, F. Meng, C. Li et al., “Human umbilical cord mesenchymal stromal cells rescue mice from acetaminophen-induced acute liver failure,” Cytotherapy, vol. 16, no. 9, pp. 1207–1219, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Gan, F. Meng, X. Zhou et al., “Hematopoietic recovery of acute radiation syndrome by human superoxide dismutase-expressing umbilical cord mesenchymal stromal cells,” Cytotherapy, vol. 17, no. 4, pp. 403–417, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Tang, Q. Li, F. Meng et al., “Therapeutic potential of hgf-expressing human umbilical cord mesenchymal stem cells in mice with acute liver failure,” International Journal of Hepatology, vol. 2016, Article ID 5452487, 13 pages, 2016. View at Publisher · View at Google Scholar
  36. S. Hänzelmann, F. Beier, E. G. Gusmao et al., “Replicative senescence is associated with nuclear reorganization and with dna methylation at specific transcription factor binding sites,” Clinical Epigenetics, vol. 7, article no. 19, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Schellenberg, S. Joussen, K. Moser et al., “Matrix elasticity, replicative senescence and DNA methylation patterns of mesenchymal stem cells,” Biomaterials, vol. 35, no. 24, pp. 6351–6358, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Zhai, X. Chen, D. Yu et al., “Histone deacetylase inhibitor valproic acid promotes the induction of pluripotency in mouse fibroblasts by suppressing reprogramming-induced senescence stress,” Experimental Cell Research, vol. 337, no. 1, pp. 61–67, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. X. Chen, Y. Zhai, D. Yu, J. Cui, J.-F. Hu, and W. Li, “Valproic acid enhances iPSC induction from human bone marrow-derived cells through the suppression of reprogramming-induced senescence,” Journal of Cellular Physiology, vol. 231, no. 8, pp. 1719–1727, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Saferali, J. Lee, D. D. Sin, F. N. Rouhani, M. L. Brantly, and A. J. Sandford, “Longer telomere length in COPD patients with α1- antitrypsin deficiency independent of lung function,” PLoS ONE, vol. 9, no. 4, Article ID e95600, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. F. El Bouazzaoui, P. Henneman, P. Thijssen et al., “Adipocyte telomere length associates negatively with adipocyte size, whereas adipose tissue telomere length associates negatively with the extent of fibrosis in severely obese women,” International Journal of Obesity, vol. 38, no. 5, pp. 746–749, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Marthandan, M. Baumgart, S. Priebe et al., “Conserved senescence associated genes and pathways in primary human fibroblasts detected by RNA-seq,” PLoS ONE, vol. 11, no. 5, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. A.-N. Ma, H. Wang, R. Guo et al., “Targeted gene suppression by inducing de novo DNA methylation in the gene promoter,” Epigenetics and Chromatin, vol. 7, no. 1, article no. 20, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. X. Zhao, X. Liu, G. Wang et al., “Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells,” Oncotarget, vol. 7, no. 32, pp. 51349–51364, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Zhang, B. Zhong, M. Chen et al., “Epigenetic reprogramming reverses the malignant epigenotype of the MMP/TIMP axis genes in tumor cells,” International Journal of Cancer, vol. 134, no. 7, pp. 1583–1594, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Sun, W. Li, Y. Sun et al., “A novel antisense long noncoding RNA within the IGF1R gene locus is imprinted in hematopoietic malignancies,” Nucleic acids research, vol. 42, no. 15, pp. 9588–9601, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Bernadotte, V. M. Mikhelson, and I. M. Spivak, “Markers of cellular senescence. Telomere shortening as a marker of cellular senescence,” Aging, vol. 8, no. 1, pp. 3–11, 2016. View at Publisher · View at Google Scholar
  48. E. Sikora, A. Bielak-Zmijewska, and G. Mosieniak, “Cellular senescence in ageing, age-related disease and longevity,” Current Vascular Pharmacology, vol. 12, no. 5, pp. 698–706, 2014. View at Google Scholar · View at Scopus
  49. N. Ishikawa, K.-I. Nakamura, N. Izumiyama-Shimomura et al., “Changes of telomere status with aging: an update,” Geriatrics and Gerontology International, vol. 16, pp. 30–42, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Matos, A. Gouveia, and H. Almeida, “Copper ability to induce premature senescence in human fibroblasts,” Age, vol. 34, no. 4, pp. 783–794, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Purcell, A. Kruger, and M. A. Tainsky, “Gene expression profiling of replicative and induced senescence,” Cell Cycle, vol. 13, no. 24, pp. 3927–3937, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Chandra and K. Kirschner, “Chromosome organisation during ageing and senescence,” Current Opinion in Cell Biology, vol. 40, pp. 161–167, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. I. Fridlyanskaya, L. Alekseenko, and N. Nikolsky, “Senescence as a general cellular response to stress: a mini-review,” Experimental Gerontology, vol. 72, pp. 124–128, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Chen, S. Patschan, and M. S. Goligorsky, “Stress-induced premature senescence of endothelial cells,” Journal of Nephrology, vol. 21, no. 3, pp. 337–344, 2008. View at Google Scholar · View at Scopus
  55. U. K. Rajarajacholan and K. Riabowol, “Aging with ING: a comparative study of different forms of stress induced premature senescence,” Oncotarget, vol. 6, no. 33, pp. 34118–34127, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. K. B. U. Choo, L. Tai, K. S. Hymavathee et al., “Oxidative stress-induced premature senescence in Wharton's jelly-derived mesenchymal stem cells,” International Journal of Medical Sciences, vol. 11, no. 11, pp. 1201–1207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. M. J. Choi, B. K. Kim, K. Y. Park, T. Yokozawa, Y. O. Song, and E. J. Cho, “Anti-aging effects of cyanidin under a stress-induced premature senescence cellular system,” Biological and Pharmaceutical Bulletin, vol. 33, no. 3, pp. 421–426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Schellenberg, Q. Lin, H. Schüler et al., “Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks,” Aging, vol. 3, no. 9, pp. 873–888, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Wang and S. Hekimi, “Mitochondrial dysfunction and longevity in animals: untangling the knot,” Science, vol. 350, no. 6265, pp. 1204–1207, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. O. Hashizume, S. Ohnishi, T. Mito et al., “Epigenetic regulation of the nuclear-coded GCAT and SHMT2 genes confers human age-associated mitochondrial respiration defects,” Scientific Reports, vol. 5, Article ID 10434, 2015. View at Publisher · View at Google Scholar
  61. B. Liu, Q. Du, L. Chen et al., “CpG methylation patterns of human mitochondrial DNA,” Scientific Reports, vol. 6, Article ID 23421, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Dennerlein and P. Rehling, “Human mitochondrial COX1 assembly into cytochrome c oxidase at a glance,” Journal of Cell Science, vol. 128, no. 5, pp. 833–837, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Jjingo, A. B. Conley, S. V. Yi, V. V. Lunyak, and I. King Jordan, “On the presence and role of human gene-body DNA methylation,” Oncotarget, vol. 3, no. 4, pp. 462–474, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Hellman and A. Chess, “Gene body-specific methylation on the active X chromosome,” Science, vol. 315, no. 5815, pp. 1141–1143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. M. P. Ball, J. B. Li, Y. Gao et al., “Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells,” Nature Biotechnology, vol. 27, no. 4, pp. 361–368, 2009. View at Publisher · View at Google Scholar
  66. T. Hamidi, A. K. Singh, and T. Chen, “Genetic alterations of DNA methylation machinery in human diseases,” Epigenomics, vol. 7, no. 2, pp. 247–265, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. E. Li, T. H. Bestor, and R. Jaenisch, “Targeted mutation of the DNA methyltransferase gene results in embryonic lethality,” Cell, vol. 69, no. 6, pp. 915–926, 1992. View at Publisher · View at Google Scholar · View at Scopus
  68. J. R. Weaver, M. Susiarjo, and M. S. Bartolomei, “Imprinting and epigenetic changes in the early embryo,” Mammalian Genome, vol. 20, no. 9-10, pp. 532–543, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. F. Uysal, G. Akkoyunlu, and S. Ozturk, “Dynamic expression of DNA methyltransferases (DNMTs) in oocytes and early embryos,” Biochimie, vol. 116, pp. 103–113, 2015. View at Publisher · View at Google Scholar · View at Scopus